← Back to Search

Procedure

Imaging Session for Retinal Disease

N/A

Recruiting

Research Sponsored by Optos, PLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Glaucoma subjects who have a history of visual field loss and RNFL or optic nerve changes

Subjects who have been diagnosed with retinal pathology and/or glaucoma that affects the posterior pole region including the macula and/or optic nerve

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

"This trial aims to capture images using the P200TxE device in eyes with diseases."

Who is the study for?

This trial is for adults over 22 with full legal capacity to consent, who have been diagnosed with retinal diseases affecting the back of the eye, including glaucoma with visual field loss and nerve changes. Participants must be able to follow clinical staff instructions and tolerate eye imaging.Check my eligibility

What is being tested?

The study aims to collect images from diseased eyes using a device called P200TxE. It's not testing a treatment but rather gathering data on how this device performs in capturing details of various retinal conditions.See study design

What are the potential side effects?

Since this trial involves image collection without any medical or drug intervention, there are no direct side effects related to treatments being tested. Discomfort from bright lights or positioning during imaging may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have glaucoma with vision loss and changes in my optic nerve.

Select...

I have been diagnosed with an eye condition affecting the back part of my eye.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of images

Trial Design

1Treatment groups

Experimental Treatment

Group I: Imaging SessionExperimental Treatment1 Intervention

Various scans will be captured

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

P200TxE

2019

N/A

~10

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Optos, PLCLead Sponsor

17 Previous Clinical Trials

3,415 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it presently possible for individuals to enroll in this clinical trial?

"As per clinicaltrials.gov, this investigation is actively seeking volunteers. The trial was initially uploaded on January 31st, 2024 and the most recent update occurred on February 13th, 2024."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

P200TxE Diseased Eye Image Collection

2024. "P200TxE Diseased Eye Image Collection". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06269666.

All > Cincinnati > Edmonton